No black box warning on record for Revuforj

As of the latest FDA labeling reviewed, Revuforj (REVUMENIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Revuforj medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity : Can cause fetal harm. Advise females of reproductive potential and males with female partners of reproductive potential of potential risk to a fetus and to use effective contraception . ( 5.3 , 8.1 , 8.3 ) 5.1 Differentiation Syndrome REVUFORJ can cause fatal or life-threatening differentiation syndrome (DS). Symptoms of differentiation syndrome,

No black box warning on record for Revuforj

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity : Can cause fetal harm. Advise females of reproductive potential and males with female partners of reproductive potential of potential risk to a fetus and to use effective contraception . ( 5.3 , 8.1 , 8.3 ) 5.1 Differentiation Syndrome REVUFORJ can cause fatal or life-threatening differentiation syndrome (DS). Symptoms of differentiation syndrome,

Revuforj Black Box Warning

No black box warning on record for Revuforj

Other warnings & precautions

Revuforj Black Box Warning

No black box warning on record for Revuforj

Other warnings & precautions